Certainly. The proposal Europe-wide, and certainly what we would love to see in Canada, is the notion of a national strategy. What I didn't mention is that part of a national strategy would include, for instance, the recognition, as you say, of some of the social and psychological challenges and specific supports for that. Also one of the big challenges is with people getting appropriately diagnosed. Sometimes it may take 10, 20, 30 years to get an accurate diagnosis of a rare disease, even though there may be experts in Canada who could. So part of it is educating GPs and pediatricians so that they're more aware of what these rare diseases are, recognizing the possibilities, and having specialists they can refer them to.
So again from a federal point of view, being able to support an overall framework that looks beyond just the drugs, as you're saying quite appropriately, is extremely important. We think that only the federal government can play that kind of a leadership role.